Autistic People Against Neuroleptic Abuse

Metadata sources used for this reference

OpenAlex Crossref OpenCitations
Learn more about the sources used

Murray, D. (2019). Autistic People Against Neuroleptic Abuse. In Autistic Community and the Neurodiversity Movement (pp. 51-63). Springer Singapore. https://doi.org/10.1007/978-981-13-8437-0_4

Publication date: 7 Nov 2019 Added to AutiHub: 6 Jul 2026 Type: Book chapter Article language: English
OpenAlex source Publisher source (DOI) Full text

This publication is integrated into AutiHub through:

Authors

Publication authors
1
Publication authors identified as autistic
1 / 1 (100.0%)
  1. Dinah Murray *

Abstract

Abstract In 1998, Dinah Murray founded APANA (Autistic People Against Neuroleptic Abuse), an autistic-led campaign in the UK to stop the overuse of drugs being given to people with intellectual disabilities. The campaign subverted the medicalization of “challenging behavior” and focused on three cases studies of institutionalized autistic adults who were being overprescribed. Murray compiled statistics on their medications and their visits to doctors, found allies, began spreading the message via the internet and using legal recourse. Espousing a non-pathological model of autism, APANA raised awareness of the harms of overmedication in the learning disability world and, perhaps, more caution in the psychiatric world. It may have impacted on some government guidelines, and on the author’s reputation as resourceful and reasonable, which benefitted her future activism.

Bibliography cited by this reference

Cited references are imported from external metadata sources when they are available. The list may be partial.

Bibliography inclusion overview

These indicators describe the cited bibliography imported for this publication. Cited-reference metrics use the cited-reference total as denominator. Cited-author metrics state whether they use all cited-author occurrences or only occurrences linked to authors already integrated in the AutiHub database. They use cached links between cited authors and authors integrated in the AutiHub database. Last computed: 16 Aug 2026 11:31.

Cited references
17
Total cited references integrated for this publication.
Cited references with an identified autistic author
0 / 17 (0.0%)
Cited author occurrences identified as autistic
0 / 27 (0.0%)
Among occurrences linked to AutiHub author records: 0 / 5 (0.0%). Distinct cited authors identified as autistic: 0 / 26 (0.0%).
Cited author occurrences linked to AutiHub author records
5 / 27 (18.5%)
Distinct linked cited authors: 5 / 26 (19.2%)
Linked cited-author occurrences not identified as autistic
5 / 5 (100.0%)
Among linked cited-author occurrences only. Across all cited-author occurrences: 5 / 27 (18.5%). Distinct linked cited authors not identified as autistic: 5 / 5 (100.0%).
  1. (2006). Catatonia in Autism Spectrum Disorders . Elsevier.
    Type: Book DOI: 10.1016/s0074-7742(05)x1078-9 OpenAlex: https://openalex.org/W601815728
    OpenAlex
  2. Autism Europe. (1998). Draft code of good practice on prevention of violence against persons with autism. Brussels: Autism-Europe.
    Type: Other
    Crossref
  3. Lorna Wing , Amitta Shah (2000). Catatonia in autistic spectrum disorders . British Journal of Psychiatry, 176(4), 357-362. Royal College of Psychiatrists.
    Type: Article DOI: 10.1192/bjp.176.4.357 OpenAlex: https://openalex.org/W2155207255
    Crossref OpenAlex OpenCitations
  4. J. Brylewski , L. Duggan (1999). Review: Antipsychotic medication for challenging behaviour in people with intellectual disability: a systematic review of randomized controlled trials . Journal of Intellectual Disability Research, 43(5), 360-371. Wiley.
    Type: Article DOI: 10.1046/j.1365-2788.1999.043005360.x OpenAlex: https://openalex.org/W1520511209
    Crossref OpenAlex OpenCitations
  5. C. Kiernan , D. Reeves , A. Alborz (1995). The use of anti‐psychotic drugs with adults with learning disabilities and challenging behaviour . Journal of Intellectual Disability Research, 39(4), 263-274. Wiley.
    Type: Article DOI: 10.1111/j.1365-2788.1995.tb00518.x OpenAlex: https://openalex.org/W1990730979
    Crossref OpenAlex OpenCitations
  6. R. S. Shiwach , T. J. Carmody (1998). Prolactogenic effects of risperidone in male patients — a preliminary study . Acta Psychiatrica Scandinavica, 98(1), 81-83. Wiley.
    Type: Article DOI: 10.1111/j.1600-0447.1998.tb10046.x OpenAlex: https://openalex.org/W2079889205
    Crossref OpenAlex OpenCitations
  7. D Manchester (1993). Neuroleptics, learning disability, and the community: some history and mystery. BMJ, 307(6897), 184-187. BMJ.
    Type: Article DOI: 10.1136/bmj.307.6897.184 OpenAlex: https://openalex.org/W2030941842
    Crossref OpenAlex OpenCitations
  8. Richard Tranter , David Healy (1998). Neuroleptic discontinuation syndromes . Journal of Psychopharmacology, 12(4), 401-406. SAGE Publications.
    Type: Article DOI: 10.1177/026988119801200412 OpenAlex: https://openalex.org/W2069460670
    Crossref OpenAlex OpenCitations
  9. D. Branford (1996). Factors associated with the successful or unsuccessful withdrawal of antipsychotic drug therapy prescribed for people with learning disabilities . Journal of Intellectual Disability Research, 40(4), 322-329. Wiley.
    Type: Article DOI: 10.1111/j.1365-2788.1996.tb00637.x OpenAlex: https://openalex.org/W4246661162
    Crossref OpenCitations
  10. Helen McConachie , David Mason , Jeremy R. Parr , Deborah Garland , Colin Wilson , Jacqui Rodgers (2018). Enhancing the Validity of a Quality of Life Measure for Autistic People . Journal of Autism and Developmental Disorders, 48(5), 1596-1611. Springer Science and Business Media LLC.
    Type: Article DOI: 10.1007/s10803-017-3402-z OpenAlex: https://openalex.org/W2768942203
    Crossref OpenAlex OpenCitations
  11. Richard Ashcroft , Bill Fraser , Michael Kerr , Zahir Ahmed (2001). Are antipsychotic drugs the right treatment for challenging behaviour in learning disability?: The place of a randomised trial . Journal of Medical Ethics, 27(5), 338-343. BMJ.
    Type: Article DOI: 10.1136/jme.27.5.338 OpenAlex: https://openalex.org/W2139033959
    Crossref OpenAlex OpenCitations
  12. Murray, D. (1999). ‘Potions, pills and human rights’ in opening volume of Good Autism Practice (long version). http://www.autismusundcomputer.de/potions.en.html .
    Type: Other
    Crossref
  13. Melissa DeFilippis , Karen Dineen Wagner (2025). Treatment of Autism Spectrum Disorder in Children and Adolescents . Psychopharmacology Bulletin, 46(2), 18-41. Medworks Media Inc..
    Type: Article DOI: 10.64719/pb.4346 OpenAlex: https://openalex.org/W2540591581
    OpenAlex
  14. D. Branford (1996). Factors associated with the successful or unsuccessful withdrawal of antipsychotic drug therapy prescribed for people with learning disabilities . Journal of Intellectual Disability Research, 40(4), 322-329. Wiley.
    Type: Article DOI: 10.1046/j.1365-2788.1996.772772.x OpenAlex: https://openalex.org/W2069180118
    OpenAlex
  15. Unwin, G., & Deb, S. (2006). Your guide to taking medicine for behaviour problems: Easy read. University of Birmingham. https://www.birmingham.ac.uk/Documents/college-les/psych/ld/LDEasyReadGuide.pdf .
    Type: Other
    Crossref
  16. Alexander, R., Branford, D., & Devapriam, J. (2016). Psychotropic drug prescribing for people with intellectual disability, mental health problems and/or behaviours that challenge: Practice guidelines. (Faculty Report No. FR/ID/09). https://www.rcpsych.ac.uk .
    Type: Other
    Crossref
  17. M DeFilippis (2016). DeFilippis, M., & Wagner, K. D. (2016). Treatment of autism spectrum disorder in children and adolescents. Psychopharmacology Bulletin, 46(2), 18–41. Psychopharmacology Bulletin, 46(2), 18.
    Type: Other
    Crossref